Verity Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,122
Closed -$387K 171
2020
Q3
$387K Sell
10,122
-134
-1% -$5.16K 0.29% 85
2020
Q2
$360K Buy
10,256
+936
+10% +$33.7K 0.33% 74
2020
Q1
$304K Sell
9,320
-694
-7% -$27.1K 0.38% 83
2019
Q4
$453K Sell
10,014
-353
-3% -$14.8K 0.45% 73
2019
Q3
$422K Sell
10,367
-1,312
-11% -$55.6K 0.44% 74
2019
Q2
$502K Buy
11,679
+721
+7% +$27.7K 0.56% 56
2019
Q1
$421K Sell
10,958
-591
-5% -$22.6K 0.49% 61
2018
Q4
$408K Buy
11,549
+515
+5% +$18.7K 0.55% 48
2018
Q3
$425K Buy
11,034
+898
+9% +$31.4K 0.42% 51
2018
Q2
$331K Buy
10,136
+1,474
+17% +$44.5K 0.3% 68
2018
Q1
$237K Buy
8,662
+635
+8% +$17.3K 0.22% 91
2017
Q4
$224K Buy
8,027
+860
+12% +$23.7K 0.17% 113
2017
Q3
$202K Sell
7,167
-1,257
-15% -$34.7K 0.15% 112
2017
Q2
$234K Buy
+8,424
New +$224K 0.18% 98

Other funds holding BSX

Verity Asset Management's BSX Position: Q4 2020 in Review

Verity Asset Management sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 10,122 shares — an estimated $387K sold.

Verity Asset Management first reported a position in BSX in Q2 2017 and held it in 14 quarters. The position peaked at $502K in Q2 2019. 863 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • Verity Asset Management reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
  • Verity Asset Management sold 10,122 Boston Scientific shares in Q4 2020, an estimated $387K.
  • Verity Asset Management first reported a position in Boston Scientific in Q2 2017 and held it in 14 quarters.
  • Verity Asset Management's Boston Scientific position peaked at $502K in Q2 2019.
  • 863 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Verity Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.